In the current study, we observed that in AD cellular models: (1) MiR-125b inhibition repressed cell apoptosis and inflammation but promoted neurite outgrowth; meanwhile, it elevated FOXQ1 but attenuated PTGS2 and CDK5. This evidence concerns the gene CDK5 and Alzheimer disease.